- ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Comparative Bioavailability of Lenvatinib 10 mg Capsules: A Two-Part, Single-Dose, Open-Label, Randomized, Six-Sequence, Three-Treatment, Three-Period, Crossover Pilot Study in Healthy Subjects Under Fasting and Fed Conditions.
This study looks at how a cancer drug called Lenvatinib is absorbed by the body. It helps us understand if different versions of the drug work the same way, and if food affects this absorption. It's for adults, and you don't need to have cancer to take part.
Portugal - ongoing, recruitingPhase I and Phase II (Integrated)- Other
Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors
This study is testing a new treatment for children and young adults with certain high-risk cancers. It uses special immune cells grown in a lab to help their bodies fight the cancer. The main goal is to check how safe this new treatment is and if it has any serious side effects.
Czechia